RVTY Revvity
too hard · 51
Owner-earnings value$63.62
Price$152.77
Margin of safety
-58.4%
Quality gate · 51/100
⚠ sub-hurdle returns (median roic 3% < 9%)
Median ROIC3.2%
Gross margin55.0%
Net debt / EBITDA3.4x
FCF conversion93%
Share count / yr-3.9%
Profitable years4/4
Moat & management
Owner-earnings inputs
| Owner earnings (TTM) | 558.11M |
| Owner-earnings yield | 3.3% |
| Free-cash-flow yield | 3.3% |
| Growth used (normalized) | 0.0% |
| Market-implied growth (reverse DCF) | 22.0% |
| Terminal growth | 3.0% |
| Discount rate (hurdle) | 10.2% |
Projected owner earnings
| Yr | Owner earnings | Growth | PV |
|---|---|---|---|
| 1 | 558.11M | 0.0% | 506.66M |
| 2 | 559.97M | 0.3% | 461.48M |
| 3 | 563.71M | 0.7% | 421.73M |
| 4 | 569.34M | 1.0% | 386.68M |
| 5 | 576.93M | 1.3% | 355.71M |
| 6 | 586.55M | 1.7% | 328.30M |
| 7 | 598.28M | 2.0% | 303.99M |
| 8 | 612.24M | 2.3% | 282.41M |
| 9 | 628.57M | 2.7% | 263.21M |
| 10 | 647.42M | 3.0% | 246.11M |
Recent news
score · 8 articles
- Revvity (RVTY): Buy, Sell, or Hold Post Q2 Earnings?
- Here's Why You Should Retain Revvity Stock in Your Portfolio for Now
- 1 Unpopular Stock That Deserves Some Love and 2 Facing Headwinds
- RVTY Launches New Kit in Europe for Newborn Type 1 Diabetes Detection
- Sector Update: Healthcare Stocks Advance Late Afternoon
- Top Midday Stories: Oracle's Data Center Delay; People Withdraws MGM Offer; Revvity's New Diabetes Test
- Is Revvity Stock Outperforming the Dow?
- Why Revvity (RVTY) Is Getting Attention Today
⚠ maintenance capex ≈ min(capex, D&A), capped at FCF · Price pays for ~22%/yr owner-earnings growth over 10y (reverse DCF); model credits 0%.